Rosiglitazone indications: Difference between revisions
Jump to navigation
Jump to search
AkylazGiE1 (talk | contribs) No edit summary |
Matt Pijoan (talk | contribs) m (Reverted edits by AkylazGiE1 (talk) to last revision by NNethala) |
||
| Line 1: | Line 1: | ||
{{CMG}} | |||
===Indications=== | |||
AVANDIA is indicated as an adjunct to diet and exercise to improve glycemic control in | AVANDIA is indicated as an adjunct to diet and exercise to improve glycemic control in | ||
patients with type 2 diabetes mellitus. | patients with type 2 diabetes mellitus. | ||
*AVANDIA is indicated as monotherapy. | *AVANDIA is indicated as monotherapy. | ||
*AVANDIA is also indicated for use in combination with a sulfonylurea, metformin, or | *AVANDIA is also indicated for use in combination with a sulfonylurea, metformin, or insulin when diet, exercise, and a single agent do not result in adequate glycemic control. For patients inadequately controlled with a maximum dose of a sulfonylurea or metformin, AVANDIA should be added to, rather than substituted for, a sulfonylurea or metformin. | ||
insulin when diet, exercise, and a single agent do not result in adequate glycemic control. | *AVANDIA is also indicated for use in combination with a sulfonylurea plus metformin when diet, exercise, and both agents do not result in adequate glycemic control. | ||
For patients inadequately controlled with a maximum dose of a sulfonylurea or | <br> | ||
metformin, AVANDIA should be added to, rather than substituted for, a sulfonylurea or | <br> | ||
metformin. | ---- | ||
*AVANDIA is also indicated for use in combination with a sulfonylurea plus metformin | <br> | ||
when diet, exercise, and both agents do not result in adequate glycemic control. | {{FDA}} | ||
Revision as of 14:39, 20 December 2011
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Indications
AVANDIA is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.
- AVANDIA is indicated as monotherapy.
- AVANDIA is also indicated for use in combination with a sulfonylurea, metformin, or insulin when diet, exercise, and a single agent do not result in adequate glycemic control. For patients inadequately controlled with a maximum dose of a sulfonylurea or metformin, AVANDIA should be added to, rather than substituted for, a sulfonylurea or metformin.
- AVANDIA is also indicated for use in combination with a sulfonylurea plus metformin when diet, exercise, and both agents do not result in adequate glycemic control.
Adapted from the FDA Package Insert.